Works matching IS 08876924 AND DT 2008 AND VI 22 AND IP 12

Results: 32

How little is too much? p53 inactivation: from laboratory cutoff to biological basis of chemotherapy resistance.

Published in:

2008

By:

Zenz, T.;
Häbe, S.;
Denzel, T.;
Winkler, D.;
Döhner, H.;
Stilgenbauer, S.

Publication type:

Letter

Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independent data set.

Published in:

2008

By:

Bishton, M. J.;
Hicks, R. J.;
Prince, H. M.;
Ritchie, D. S.;
Wolf, M.;
Seymour, J. F.

Publication type:

Letter

Reply to ‘Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independence data set’ by Mark J Bishton et al.

Published in:

2008

By:

Porrata, L. F.;
Ristow, K.;
Witzig, T. E.;
Tuinistra, N.;
Habermann, T. M.;
Inwards, D. J.;
Ansell, S. M.;
Micallef, I. N.;
Johnston, P. B.;
Markovic, S. N.

Publication type:

Letter

Spurious elevation of the cerebrospinous fluid white cell counts in three patients receiving liposomal cytarabine as part of post-remission therapy.

Published in:

2008

By:

Swords, R.;
O'Rafferty, C.;
Giles, F.;
Browne, P.

Publication type:

Letter

Oncolytic virotherapy for multiple myeloma using a tumour-specific double-deleted vaccinia virus.

Published in:

2008

By:

Deng, H.;
Tang, N.;
Stief, A. E.;
Mehta, N.;
Baig, E.;
Head, R.;
Sleep, G.;
Yang, X.-Z.;
McKerlie, C.;
Trudel, S.;
Stewart, A. K.;
McCart, J. A.

Publication type:

Letter

PKR is activated in MDS patients and its subcellular localization depends on disease severity.

Published in:

2008

By:

Follo, M. Y.;
Finelli, C.;
Mongiorgi, S.;
Clissa, C.;
Bosi, C.;
Martinelli, G.;
Blalock, W. L.;
Cocco, L.;
Martelli, A. M.

Publication type:

Letter

An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia.

Published in:

2008

By:

Agarwal, A.;
Eide, C. A.;
Harlow, A.;
Corbin, A. S.;
Mauro, M. J.;
Druker, B. J.;
Corless, C. L.;
Heinrich, M. C.;
Deininger, M. W.

Publication type:

Case Study

Cotransplantation of mesenchymal cells and a higher relapse rate: a role for HLA-G molecules?

Published in:

2008

By:

Rizzo, R.;
Campioni, D.;
Lanza, F.;
Baricordi, O. R.

Publication type:

Letter

Notch inhibition blocks multiple myeloma cell-induced osteoclast activation.

Published in:

2008

By:

Schwarzer, R.;
Kaiser, M.;
Acikgoez, O.;
Heider, U.;
Mathas, S.;
Preissner, R.;
Sezer, O.;
Doerken, B.;
Jundt, F.

Publication type:

Letter

Improving minimal residual disease detection in precursor B-ALL based on immunoglobulin-κ and heavy-chain gene rearrangements.

Published in:

2008

By:

Sutton, R.;
Bahar, A. Y.;
Kwan, E.;
Giles, J. E.;
Venn, N. C.;
Tran, S.;
Hackenberg, N.;
Pozza, L. Dalla;
Marshall, G. M.;
Haber, M.;
van der Velden, V. H. J.;
Norris, M. D.

Publication type:

Letter

Novel gain-of-function mutation in the extracellular domain of the PDGFRA gene in infant acute lymphoblastic leukemia with t(4;11)(q21;q23).

Published in:

2008

By:

Hiwatari, M.;
Ono, R.;
Taki, T.;
Hishiya, A.;
Ishii, E.;
Kitamura, T.;
Hayashi, Y.;
Nosaka, T.

Publication type:

Letter

Clinical and biological significance of RAS mutations in multiple myeloma.

Published in:

2008

By:

Chng, W. J.;
Gonzalez-Paz, N.;
Price-Troska, T.;
Jacobus, S.;
Rajkumar, S. V.;
Oken, M. M.;
Kyle, R. A.;
Henderson, K. J.;
Van Wier, S.;
Greipp, P.;
Van Ness, B.;
Fonseca, R.

Publication type:

Letter

Large interindividual differences in cellular sensitivity to calicheamicin may influence gemtuzumab ozogamicin response in acute myeloid leukemia.

Published in:

2008

By:

Goemans, B. F.;
Zwaan, C. M.;
Vijverberg, S. J. H.;
Loonen, A. H.;
Creutzig, U.;
Hählen, K.;
Reinhardt, D.;
Gibson, B. E. S.;
Cloos, J.;
Kaspers, G. J. L.;
Hählen, K

Publication type:

Letter

A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia.

Published in:

2008

By:

Martelli, M. P.;
Manes, N.;
Liso, A.;
Pettirossi, V.;
Galletti, B. Verducci;
Bigerna, B.;
Pucciarini, A.;
De Marco, M. F.;
Pallotta, M. T.;
Bolli, N.;
Sborgia, M.;
di Raimondo, F.;
Fabbiano, F.;
Meloni, G.;
Specchia, G.;
Martelli, M. F.;
Falini, B.

Publication type:

Letter

Highly sensitive and quantitative detection of BCR-ABL kinase domain mutations by ligation PCR.

Published in:

2008

By:

Pelz-Ackermann, O.;
Cross, M.;
Pfeifer, H.;
Deininger, M.;
Wang, S.-Y.;
Al-Ali, H. K.;
Niederwieser, D.;
Lange, T.

Publication type:

Letter

Etiology of common childhood acute lymphoblastic leukemia: the adrenal hypothesis.

Published in:

Leukemia (08876924), 2008, v. 22, n. 12, p. 2137, doi. 10.1038/leu.2008.212

By:

Schmiegelow, K.;
Vestergaard, T.;
Nielsen, S. M.;
Hjalgrim, H.

Publication type:

Article

Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase.

Published in:

2008

By:

Cortes, J.;
Kim, D.-W.;
Raffoux, E.;
Martinelli, G.;
Ritchie, E.;
Roy, L.;
Coutre, S.;
Corm, S.;
Hamerschlak, N.;
Tang, J.-L.;
Hochhaus, A.;
Khoury, H. J.;
Brümmendorf, T. H.;
Michallet, M.;
Rege-Cambrin, G.;
Gambacorti-Passerini, C.;
Radich, J. P.;
Ernst, T.;
Zhu, C.;
Van Tornout, J. M. A.

Publication type:

journal article

The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation.

Published in:

2008

By:

Tavor, S.;
Eisenbach, M.;
Jacob-Hirsch, J.;
Golan, T.;
Petit, I.;
BenZion, K.;
Kay, S.;
Baron, S.;
Amariglio, N.;
Deutsch, V.;
Naparstek, E.;
Rechavi, G.

Publication type:

journal article

Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2008, v. 22, n. 12, p. 2184, doi. 10.1038/leu.2008.241

By:

Weinberg, J. B.;
Volkheimer, A. D.;
Mihovilovic, M.;
Jiang, N.;
Chen, Y.;
Bond, K.;
Moore, J. O.;
Gockerman, J. P.;
Diehl, L. F.;
de Castro, C. M.;
Rizzieri, D. A.;
Levesque, M. C.;
DeKroon, R.;
Strittmatter, W. J.

Publication type:

Article

Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases.

Published in:

Leukemia (08876924), 2008, v. 22, n. 12, p. 2208, doi. 10.1038/leu.2008.242

By:

De Keersmaecker, K.;
Versele, M.;
Cools, J.;
Superti-Furga, G.;
Hantschel, O.

Publication type:

Article

Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells.

Published in:

Leukemia (08876924), 2008, v. 22, n. 12, p. 2159, doi. 10.1038/leu.2008.243

By:

Nishioka, C.;
Ikezoe, T.;
Yang, J.;
Koeffler, H. P.;
Yokoyama, A.

Publication type:

Article

ICER expression inhibits leukemia phenotype and controls tumor progression.

Published in:

Leukemia (08876924), 2008, v. 22, n. 12, p. 2217, doi. 10.1038/leu.2008.244

By:

Pigazzi, M.;
Manara, E.;
Baron, E.;
Basso, G.

Publication type:

Article

Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.

Published in:

2008

By:

Krejsgaard, T.;
Gjerdrum, L. M.;
Ralfkiaer, E.;
Lauenborg, B.;
Eriksen, K. W.;
Mathiesen, A.-M.;
Bovin, L. F.;
Gniadecki, R.;
Geisler, C.;
Ryder, L. P.;
Zhang, Q.;
Wasik, M. A.;
Ødum, N.;
Woetmann, A.;
Odum, N

Publication type:

journal article

SOCS2: inhibitor of JAK2V617F-mediated signal transduction.

Published in:

Leukemia (08876924), 2008, v. 22, n. 12, p. 2169, doi. 10.1038/leu.2008.226

By:

Quentmeier, H.;
Geffers, R.;
Jost, E.;
MacLeod, R. A. F.;
Nagel, S.;
Röhrs, S.;
Romani, J.;
Scherr, M.;
Zaborski, M.;
Drexler, H. G.

Publication type:

Article

Minimal residual disease is an important predictive factor of outcome in children with relapsed ‘high-risk’ acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2008, v. 22, n. 12, p. 2193, doi. 10.1038/leu.2008.227

By:

Paganin, M.;
Zecca, M.;
Fabbri, G.;
Polato, K.;
Biondi, A.;
Rizzari, C.;
Locatelli, F.;
Basso, G.

Publication type:

Article

Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

Published in:

Leukemia (08876924), 2008, v. 22, n. 12, p. 2226, doi. 10.1038/leu.2008.230

By:

Klapper, W.;
Stoecklein, H.;
Zeynalova, S.;
Ott, G.;
Kosari, F.;
Rosenwald, A.;
Loeffler, M.;
Trümper, L.;
Pfreundschuh, M.;
Siebert, Reiner

Publication type:

Article

Regulation of IL-2 expression by transcription factor BACH2 in umbilical cord blood CD4<sup>+</sup> T cells.

Published in:

Leukemia (08876924), 2008, v. 22, n. 12, p. 2201, doi. 10.1038/leu.2008.234

By:

Lesniewski, M. L.;
Haviernik, P.;
Weitzel, R. P.;
Kadereit, S.;
Kozik, M. M.;
Fanning, L. R.;
Yang, Y. C.;
Hegerfeldt, Y.;
Finney, M. R.;
Ratajczak, M. Z.;
Greco, N.;
Paul, P.;
Maciejewski, J.;
Laughlin, M. J.

Publication type:

Article

The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis.

Published in:

Leukemia (08876924), 2008, v. 22, n. 12, p. 2247, doi. 10.1038/leu.2008.235

By:

Terpos, E.;
Kastritis, E.;
Roussou, M.;
Heath, D.;
Christoulas, D.;
Anagnostopoulos, N.;
Eleftherakis-Papaiakovou, E.;
Tsionos, K.;
Croucher, P.;
Dimopoulos, M. A.

Publication type:

Article

Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.

Published in:

2008

By:

Nguyen, K.;
Devidas, M.;
Cheng, S.-C.;
La, M.;
Raetz, E. A.;
Carroll, W. L.;
Winick, N. J.;
Hunger, S. P.;
Gaynon, P. S.;
Loh, M. L.;
Children's Oncology Group

Publication type:

journal article

A role for IFN-lambda1 in multiple myeloma B cell growth.

Published in:

2008

By:

Novak, A. J.;
Grote, D. M.;
Ziesmer, S. C.;
Rajkumar, V.;
Doyle, S. E.;
Ansell, S. M.

Publication type:

journal article

The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis.

Published in:

2008

By:

Terpos, E;
Kastritis, E;
Roussou, M;
Heath, D;
Christoulas, D;
Anagnostopoulos, N;
Eleftherakis-Papaiakovou, E;
Tsionos, K;
Croucher, P;
Dimopoulos, M A

Publication type:

Correction Notice

Regulation of IL-2 expression by transcription factor BACH2 in umbilical cord blood CD4<sup>+</sup>T cells.

Published in:

2008

By:

Lesniewski, M L;
Haviernik, P;
Weitzel, R P;
Kadereit, S;
Kozik, M M;
Fanning, L R;
Yang, Y C;
Hegerfeldt, Y;
Finney, M R;
Ratajczak, M Z;
Greco, N;
Paul, P;
Maciejewski, J;
Laughlin, M J

Publication type:

Correction Notice